Title : EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma.

Pub. Date : 2021 Nov 1

PMID : 34725436






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Akt suppression following sorafenib treatment resulted in an increase of the H3K27me3 levels through a decrease in EZH2 phosphorylation at serine 21. Sorafenib AKT serine/threonine kinase 1 Homo sapiens